ロード中...
Osteoblastic flare in a patient with advanced gastric cancer after treatment with pemetrexed and oxaliplatin: implications for response assessment with RECIST criteria
<p>Abstract</p> <p>Background</p> <p>The RECIST guidelines are commonly used in phase II and III clinical trials. The correct definition of response can be controversial in some situations, as in the case we describe.</p> <p>Case presentation</p> <p...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMC
2007-06-01
|
| シリーズ: | BMC Cancer |
| オンライン･アクセス: | http://www.biomedcentral.com/1471-2407/7/94 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|